A Nature paper published Sep 2 found late-life semaglutide raised median lifespan about 12% in 20-month-old female C57BL/6 mice, from 742 days to 834 days. David Sinclair posted the paper; he is not an author. This is mice only. A human aging indication is unproved.
01
David Sinclair posted a Nature paper published Sep 2: late-life semaglutide in 20-month-old female C57BL/6 mice raised median lifespan from 742 days to 834 days (about 12%). Sinclair is not an author. This is mice only. A human aging indication is unproved.
02
Feng, Chen, and colleagues at UC Berkeley report late-life semaglutide in 20-month-old female C57BL/6 mice raised median lifespan from 742 days to 834 days (about 12%). They also report better spatial memory, glucose control, and exploratory drive versus calorie-matched controls after food intake fell 24%. This is mice only. A human aging indication is unproved.